Concepts (115)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Lung Neoplasms | 4 | 2021 | 547 | 0.910 |
Why?
|
| Frailty | 2 | 2022 | 125 | 0.330 |
Why?
|
| Esophagectomy | 3 | 2024 | 44 | 0.320 |
Why?
|
| Mediastinal Neoplasms | 1 | 2006 | 13 | 0.280 |
Why?
|
| Pheochromocytoma | 1 | 2006 | 27 | 0.270 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2007 | 135 | 0.260 |
Why?
|
| Neoplasm Staging | 2 | 2021 | 450 | 0.240 |
Why?
|
| Anastomotic Leak | 1 | 2024 | 33 | 0.220 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2007 | 400 | 0.220 |
Why?
|
| Esophageal Diseases | 1 | 2023 | 16 | 0.220 |
Why?
|
| Retrospective Studies | 7 | 2024 | 5981 | 0.220 |
Why?
|
| Esophageal Neoplasms | 1 | 2024 | 77 | 0.210 |
Why?
|
| Pneumonectomy | 3 | 2007 | 82 | 0.200 |
Why?
|
| Brazil | 1 | 2021 | 86 | 0.190 |
Why?
|
| Robotics | 1 | 2022 | 48 | 0.190 |
Why?
|
| Hernia, Hiatal | 1 | 2021 | 26 | 0.190 |
Why?
|
| Thoracic Surgery | 1 | 2022 | 64 | 0.180 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2021 | 387 | 0.180 |
Why?
|
| Databases, Factual | 1 | 2024 | 837 | 0.180 |
Why?
|
| Robotic Surgical Procedures | 1 | 2022 | 95 | 0.170 |
Why?
|
| Clinical Protocols | 1 | 2020 | 134 | 0.170 |
Why?
|
| Quality Improvement | 1 | 2024 | 425 | 0.160 |
Why?
|
| Multivariate Analysis | 1 | 2021 | 926 | 0.160 |
Why?
|
| Surgical Procedures, Operative | 1 | 2020 | 139 | 0.160 |
Why?
|
| Early Detection of Cancer | 1 | 2021 | 265 | 0.160 |
Why?
|
| Laparoscopy | 1 | 2021 | 385 | 0.140 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2020 | 665 | 0.140 |
Why?
|
| Humans | 15 | 2024 | 59343 | 0.120 |
Why?
|
| Male | 9 | 2024 | 27505 | 0.120 |
Why?
|
| Bronchodilator Agents | 2 | 2013 | 97 | 0.120 |
Why?
|
| Muscle, Smooth | 2 | 2013 | 138 | 0.120 |
Why?
|
| Preoperative Care | 2 | 2020 | 174 | 0.110 |
Why?
|
| Taste | 1 | 2013 | 32 | 0.100 |
Why?
|
| Bronchi | 1 | 2013 | 77 | 0.100 |
Why?
|
| Adenoma | 1 | 2013 | 63 | 0.100 |
Why?
|
| Female | 7 | 2024 | 30847 | 0.090 |
Why?
|
| Lymphatic Metastasis | 2 | 2007 | 70 | 0.090 |
Why?
|
| Mediastinum | 2 | 2007 | 23 | 0.090 |
Why?
|
| Calcium | 2 | 2013 | 555 | 0.090 |
Why?
|
| Aged | 7 | 2024 | 13308 | 0.090 |
Why?
|
| Ethanolamines | 1 | 2009 | 19 | 0.080 |
Why?
|
| Risk Factors | 3 | 2024 | 5001 | 0.080 |
Why?
|
| Risk Assessment | 3 | 2024 | 1908 | 0.080 |
Why?
|
| Postoperative Complications | 2 | 2022 | 1128 | 0.080 |
Why?
|
| Survival Rate | 2 | 2007 | 789 | 0.080 |
Why?
|
| Incidence | 2 | 2021 | 1232 | 0.070 |
Why?
|
| Etoposide | 1 | 2007 | 35 | 0.070 |
Why?
|
| Radiotherapy Dosage | 1 | 2007 | 79 | 0.070 |
Why?
|
| Respiration Disorders | 1 | 2007 | 20 | 0.070 |
Why?
|
| Cisplatin | 1 | 2007 | 119 | 0.070 |
Why?
|
| Pleural Neoplasms | 1 | 2007 | 17 | 0.070 |
Why?
|
| Disease-Free Survival | 1 | 2007 | 233 | 0.070 |
Why?
|
| Mesothelioma | 1 | 2007 | 26 | 0.070 |
Why?
|
| Lung Transplantation | 1 | 2006 | 47 | 0.070 |
Why?
|
| Tissue Donors | 1 | 2006 | 132 | 0.070 |
Why?
|
| Cause of Death | 1 | 2006 | 200 | 0.060 |
Why?
|
| Stomach | 1 | 2024 | 84 | 0.060 |
Why?
|
| Adult | 5 | 2023 | 15745 | 0.050 |
Why?
|
| Necrosis | 1 | 2023 | 138 | 0.050 |
Why?
|
| Morbidity | 1 | 2022 | 106 | 0.050 |
Why?
|
| Middle Aged | 4 | 2024 | 16242 | 0.050 |
Why?
|
| Lung | 2 | 2021 | 826 | 0.050 |
Why?
|
| Elective Surgical Procedures | 1 | 2022 | 104 | 0.050 |
Why?
|
| Interrupted Time Series Analysis | 1 | 2021 | 29 | 0.050 |
Why?
|
| Emergencies | 1 | 2022 | 114 | 0.050 |
Why?
|
| Surgical Mesh | 1 | 2021 | 57 | 0.050 |
Why?
|
| Herniorrhaphy | 1 | 2021 | 65 | 0.050 |
Why?
|
| Preoperative Period | 1 | 2020 | 58 | 0.040 |
Why?
|
| Logistic Models | 1 | 2024 | 1252 | 0.040 |
Why?
|
| Thoracotomy | 2 | 2013 | 45 | 0.040 |
Why?
|
| United States | 2 | 2024 | 7499 | 0.040 |
Why?
|
| Recurrence | 1 | 2021 | 577 | 0.040 |
Why?
|
| Patient Care Team | 1 | 2022 | 326 | 0.040 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2021 | 1454 | 0.040 |
Why?
|
| Walking | 1 | 2020 | 229 | 0.040 |
Why?
|
| Medicare | 1 | 2021 | 601 | 0.040 |
Why?
|
| Clinical Competence | 1 | 2022 | 677 | 0.030 |
Why?
|
| Treatment Outcome | 2 | 2020 | 5145 | 0.030 |
Why?
|
| Chloroquine | 1 | 2013 | 48 | 0.030 |
Why?
|
| In Vitro Techniques | 1 | 2013 | 475 | 0.020 |
Why?
|
| Immunohistochemistry | 1 | 2013 | 846 | 0.020 |
Why?
|
| Diagnosis, Differential | 1 | 2013 | 898 | 0.020 |
Why?
|
| Microscopy, Phase-Contrast | 1 | 2009 | 15 | 0.020 |
Why?
|
| Oscillometry | 1 | 2009 | 12 | 0.020 |
Why?
|
| Formoterol Fumarate | 1 | 2009 | 5 | 0.020 |
Why?
|
| Histamine | 1 | 2009 | 27 | 0.020 |
Why?
|
| Inositol 1,4,5-Trisphosphate | 1 | 2009 | 27 | 0.020 |
Why?
|
| Ryanodine Receptor Calcium Release Channel | 1 | 2009 | 42 | 0.020 |
Why?
|
| Biomarkers, Tumor | 1 | 2013 | 454 | 0.020 |
Why?
|
| Myocytes, Smooth Muscle | 1 | 2009 | 60 | 0.020 |
Why?
|
| Calcium Signaling | 1 | 2009 | 152 | 0.020 |
Why?
|
| Muscle Contraction | 1 | 2009 | 198 | 0.020 |
Why?
|
| Mediastinoscopy | 1 | 2007 | 6 | 0.020 |
Why?
|
| Donor Selection | 1 | 2006 | 16 | 0.020 |
Why?
|
| Prosthesis Implantation | 1 | 2007 | 30 | 0.020 |
Why?
|
| Syndrome | 1 | 2007 | 172 | 0.020 |
Why?
|
| Bronchoscopy | 1 | 2007 | 64 | 0.020 |
Why?
|
| Probability | 1 | 2006 | 172 | 0.020 |
Why?
|
| Radiography, Thoracic | 1 | 2007 | 100 | 0.020 |
Why?
|
| Reoperation | 1 | 2007 | 253 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 1 | 2013 | 3191 | 0.020 |
Why?
|
| Graft Survival | 1 | 2006 | 279 | 0.020 |
Why?
|
| Graft Rejection | 1 | 2006 | 257 | 0.020 |
Why?
|
| Survival Analysis | 1 | 2006 | 553 | 0.020 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2007 | 301 | 0.010 |
Why?
|
| Patient Selection | 1 | 2007 | 445 | 0.010 |
Why?
|
| Animals | 2 | 2013 | 19620 | 0.010 |
Why?
|
| Young Adult | 1 | 2013 | 4324 | 0.010 |
Why?
|
| Age Factors | 1 | 2006 | 1518 | 0.010 |
Why?
|
| Prognosis | 1 | 2007 | 1565 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 2006 | 2325 | 0.010 |
Why?
|
| Mice | 1 | 2013 | 10260 | 0.010 |
Why?
|
| Time Factors | 1 | 2006 | 3569 | 0.010 |
Why?
|
| Child | 1 | 2006 | 4301 | 0.010 |
Why?
|
| Adolescent | 1 | 2006 | 5921 | 0.010 |
Why?
|